25 XP   0   0   10

Organogenesis Holdings Inc
Buy, Hold or Sell?

Let's analyse Organogenesis together

PenkeI guess you are interested in Organogenesis Holdings Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Organogenesis Holdings Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Organogenesis Holdings Inc

I send you an email if I find something interesting about Organogenesis Holdings Inc.

Quick analysis of Organogenesis (30 sec.)










What can you expect buying and holding a share of Organogenesis? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
9.7%

What is your share worth?

Current worth
$2.11
Expected worth in 1 year
$2.21
How sure are you?
67.7%

+ What do you gain per year?

Total Gains per Share
$0.10
Return On Investment
4.3%

For what price can you sell your share?

Current Price per Share
$2.29
Expected price per share
$1.855 - $2.52
How sure are you?
50%

1. Valuation of Organogenesis (5 min.)




Live pricePrice per Share (EOD)

$2.29

Intrinsic Value Per Share

$-3.04 - $-3.69

Total Value Per Share

$-0.93 - $-1.58

2. Growth of Organogenesis (5 min.)




Is Organogenesis growing?

Current yearPrevious yearGrowGrow %
How rich?$278.6m$254.9m$17.7m6.5%

How much money is Organogenesis making?

Current yearPrevious yearGrowGrow %
Making money$3.4m$4.1m-$661.5k-19.1%
Net Profit Margin3.1%3.5%--

How much money comes from the company's main activities?

3. Financial Health of Organogenesis (5 min.)




What can you expect buying and holding a share of Organogenesis? (5 min.)

Welcome investor! Organogenesis's management wants to use your money to grow the business. In return you get a share of Organogenesis.

What can you expect buying and holding a share of Organogenesis?

First you should know what it really means to hold a share of Organogenesis. And how you can make/lose money.

Speculation

The Price per Share of Organogenesis is $2.285. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Organogenesis.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Organogenesis, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.11. Based on the TTM, the Book Value Change Per Share is $0.02 per quarter. Based on the YOY, the Book Value Change Per Share is $0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Organogenesis.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-0.2%0.031.1%0.031.3%0.041.7%0.010.3%
Usd Book Value Change Per Share0.041.6%0.021.1%0.052.2%0.093.8%0.073.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.041.6%0.021.1%0.052.2%0.093.9%0.073.0%
Usd Price Per Share4.09-3.18-4.61-6.72-6.59-
Price to Earnings Ratio-237.56--57.92-859.58-161.50-181.36-
Price-to-Total Gains Ratio112.05-34.52-179.52-53.39-621.83-
Price to Book Ratio1.94-1.54-2.43-12.55-9.09-
Price-to-Total Gains Ratio112.05-34.52-179.52-53.39-621.83-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.285
Number of shares437
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.020.09
Usd Total Gains Per Share0.020.09
Gains per Quarter (437 shares)10.7938.46
Gains per Year (437 shares)43.14153.85
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1043330153144
2086761307298
301291191460452
401721622614606
512152052767760
612582483920914
71301291310741068
81344334412271222
91387377413811376
101430420415341530

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%10.02.00.083.3%12.08.00.060.0%14.017.00.045.2%14.017.00.045.2%
Book Value Change Per Share3.01.00.075.0%11.01.00.091.7%14.06.00.070.0%20.011.00.064.5%20.011.00.064.5%
Dividend per Share1.00.03.025.0%1.00.011.08.3%2.00.018.010.0%3.00.028.09.7%3.00.028.09.7%
Total Gains per Share3.01.00.075.0%11.01.00.091.7%14.06.00.070.0%21.010.00.067.7%21.010.00.067.7%

Fundamentals of Organogenesis

About Organogenesis Holdings Inc

Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane in which viable cells, growth factors/cytokines, and ECM proteins in the native tissue are preserved; Novachor, a chorion membrane in which viable cells, growth factors/cytokines, and ECM proteins in the native tissue are preserved; Apligraf, a bioengineered living cell therapy that produce spectrum of cytokines and growth factors; Dermagraft, a bioengineered product that produces human collagen, ECM, proteins, cytokines, and growth factors; NuShield, dehydrated placental tissue covering amnion and chorion membranes for spongy/intermediate layer intact; and PuraPly AM, an antimicrobial barrier that enables conformability and fluid drainage. Its products also include FortiShield, a biosynthetic wound matrix for use as a temporary protective covering; PuraPly MZ, a micronized particulate version of PuraPly for the management of open wounds in the surgical setting; and CYGNUS Dual, a dehydrated placental tissue preserved to retain the ECM scaffold. The company's pipeline products include ReNu, a cryopreserved suspension used to support healing of soft tissues; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; and TransCyte, a bioengineered tissue for the treatment of partial thickness burns. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician office through direct sales representives and independent agencies. Organogenesis Holdings Inc. was founded in 1985 and is headquartered in Canton, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-11 17:06:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Organogenesis Holdings Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Organogenesis earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Organogenesis to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -0.6% means that $-0.01 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Organogenesis Holdings Inc:

  • The MRQ is -0.6%. The company is not making a profit/loss.
  • The TTM is 3.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ-0.6%TTM3.1%-3.7%
TTM3.1%YOY3.5%-0.4%
TTM3.1%5Y2.2%+0.9%
5Y2.2%10Y-9.5%+11.6%
1.1.2. Return on Assets

Shows how efficient Organogenesis is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Organogenesis to the Drug Manufacturers - Specialty & Generic industry mean.
  • -0.1% Return on Assets means that Organogenesis generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Organogenesis Holdings Inc:

  • The MRQ is -0.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 0.8%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-0.1%TTM0.8%-0.9%
TTM0.8%YOY0.9%-0.2%
TTM0.8%5Y0.6%+0.1%
5Y0.6%10Y0.2%+0.4%
1.1.3. Return on Equity

Shows how efficient Organogenesis is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Organogenesis to the Drug Manufacturers - Specialty & Generic industry mean.
  • -0.2% Return on Equity means Organogenesis generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Organogenesis Holdings Inc:

  • The MRQ is -0.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is 1.3%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-0.2%TTM1.3%-1.5%
TTM1.3%YOY1.6%-0.3%
TTM1.3%5Y-6.7%+8.0%
5Y-6.7%10Y-4.9%-1.8%

1.2. Operating Efficiency of Organogenesis Holdings Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Organogenesis is operating .

  • Measures how much profit Organogenesis makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Organogenesis to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.7% means the company generated $0.01  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Organogenesis Holdings Inc:

  • The MRQ is 0.7%. The company is operating inefficient. -1
  • The TTM is 2.3%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ0.7%TTM2.3%-1.7%
TTM2.3%YOY4.0%-1.7%
TTM2.3%5Y2.3%+0.0%
5Y2.3%10Y9.7%-7.4%
1.2.2. Operating Ratio

Measures how efficient Organogenesis is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.99 means that the operating costs are $0.99 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Organogenesis Holdings Inc:

  • The MRQ is 0.993. The company is less efficient in keeping operating costs low.
  • The TTM is 0.968. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.993TTM0.968+0.025
TTM0.968YOY0.951+0.018
TTM0.9685Y0.969-0.001
5Y0.96910Y0.948+0.021

1.3. Liquidity of Organogenesis Holdings Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Organogenesis is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.80 means the company has $2.80 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Organogenesis Holdings Inc:

  • The MRQ is 2.795. The company is able to pay all its short-term debts. +1
  • The TTM is 2.840. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.795TTM2.840-0.045
TTM2.840YOY2.753+0.087
TTM2.8405Y2.381+0.459
5Y2.38110Y2.204+0.177
1.3.2. Quick Ratio

Measures if Organogenesis is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Organogenesis to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.31 means the company can pay off $2.31 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Organogenesis Holdings Inc:

  • The MRQ is 2.314. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.373. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.314TTM2.373-0.058
TTM2.373YOY2.386-0.013
TTM2.3735Y1.938+0.435
5Y1.93810Y2.286-0.347

1.4. Solvency of Organogenesis Holdings Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Organogenesis assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Organogenesis to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.39 means that Organogenesis assets are financed with 39.4% credit (debt) and the remaining percentage (100% - 39.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Organogenesis Holdings Inc:

  • The MRQ is 0.394. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.401. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.394TTM0.401-0.006
TTM0.401YOY0.433-0.033
TTM0.4015Y0.576-0.175
5Y0.57610Y0.440+0.136
1.4.2. Debt to Equity Ratio

Measures if Organogenesis is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Organogenesis to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 65.1% means that company has $0.65 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Organogenesis Holdings Inc:

  • The MRQ is 0.651. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.668. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.651TTM0.668-0.018
TTM0.668YOY0.766-0.097
TTM0.6685Y2.441-1.773
5Y2.44110Y1.668+0.773

2. Market Valuation of Organogenesis Holdings Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Organogenesis generates.

  • Above 15 is considered overpriced but always compare Organogenesis to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -237.56 means the investor is paying $-237.56 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Organogenesis Holdings Inc:

  • The EOD is -132.718. Based on the earnings, the company is expensive. -2
  • The MRQ is -237.557. Based on the earnings, the company is expensive. -2
  • The TTM is -57.922. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-132.718MRQ-237.557+104.839
MRQ-237.557TTM-57.922-179.635
TTM-57.922YOY859.585-917.507
TTM-57.9225Y161.504-219.426
5Y161.50410Y181.361-19.857
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Organogenesis Holdings Inc:

  • The EOD is 10.342. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 18.512. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 29.776. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD10.342MRQ18.512-8.170
MRQ18.512TTM29.776-11.264
TTM29.776YOY-15.158+44.934
TTM29.7765Y3.838+25.938
5Y3.83810Y-290.907+294.745
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Organogenesis is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Organogenesis Holdings Inc:

  • The EOD is 1.082. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.937. Based on the equity, the company is underpriced. +1
  • The TTM is 1.541. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.082MRQ1.937-0.855
MRQ1.937TTM1.541+0.396
TTM1.541YOY2.428-0.887
TTM1.5415Y12.549-11.008
5Y12.54910Y9.088+3.461
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Organogenesis Holdings Inc.

3.1. Institutions holding Organogenesis Holdings Inc

Institutions are holding 44.855% of the shares of Organogenesis Holdings Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Morgan Stanley - Brokerage Accounts10.13750.004813377756643721292.7479
2023-12-31Soleus Capital Management, L.P.6.7924.06758963000-3333163-27.1073
2023-12-31Vanguard Group Inc4.06230.00055360727166508845.0555
2023-12-31BlackRock Inc3.93910.000551981872530375.1169
2023-12-31Acadian Asset Management LLC1.91720.04012529938-60306-2.3282
2023-12-31Deutsche Bank AG1.90310.0052251142624744446690.9415
2023-12-31Geode Capital Management, LLC1.28590.00071696868648063.9708
2023-12-31State Street Corporation1.06130.00031400545903896.8991
2023-12-31Dimensional Fund Advisors, Inc.1.05120.0017138714053062061.9507
2023-12-31AQR Capital Management LLC0.90250.00921190993-351767-22.8011
2023-09-30D. E. Shaw & Co LP0.82310.00361086218-184747-14.536
2023-12-31Assenagon Asset Management SA0.73630.010697167400
2023-12-31Millennium Management LLC0.7170.0017946214-373714-28.3132
2023-12-31Two Sigma Advisers, LLC0.66530.0084877900-104300-10.619
2023-12-31Renaissance Technologies Corp0.650.005485772517363125.3812
2023-12-31Charles Schwab Investment Management Inc0.6320.000983400875160.9094
2023-12-31Marshall Wace Asset Management Ltd0.6230.005782215436211578.714
2023-12-31Northern Trust Corp0.47430.000562590732710.5253
2023-09-30Citadel Advisors Llc0.46890.0004618774-1242416-66.7539
2023-12-31Two Sigma Investments LLC0.42210.0052557053225024.2095
Total 39.26414.172951814207+6434218+12.4%

3.2. Funds holding Organogenesis Holdings Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.47190.00083262035-170026-4.954
2024-03-28iShares Russell 2000 ETF1.29720.007417118358250.0482
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.80620.0037106392400
2024-01-31Fidelity Small Cap Index0.54160.0095714700102481.4547
2023-12-31Xtrackers S&P Global Infra Swap ETF 1C0.49821.221665740900
2024-03-28iShares Russell 2000 Value ETF0.44750.0134590530-374-0.0633
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.31580.003641672261001.4856
2024-02-29Fidelity Extended Market Index0.30980.0038408792-1981-0.4823
2024-03-29Schwab US Small-Cap ETF™0.26280.005834681100
2024-02-29Xtrackers S&P 500 Swap ETF 1C0.24370.012732162900
2023-12-31Schwab Small-Cap Equity0.20120.1826546500
2024-03-29Dimensional US Targeted Value ETF0.19690.007325977800
2024-02-29Vanguard Russell 2000 ETF0.19190.0095253240199368.5451
2024-03-31State St Russell Sm Cap® Indx SL Cl I0.18840.007224857000
2023-12-31Acadian Global Small-Cap Equity CIT Cl A0.18630.315524591300
2024-02-29SEI Small Cap F (SIMT)0.1830.1442415396040433.3475
2024-02-29DFA US Targeted Value I0.18030.00662379202521311.8534
2023-12-31NT R2000 Index Fund - NL0.15680.01172069792810.1359
2024-02-29MFS Blended Research Small Cap Eq R60.15630.226120622400
2024-02-29Vanguard Health Care ETF0.15270.003520152410240.5107
Total 8.98852.193711861539-48350-0.4%

3.3. Insider Transactions

Insiders are holding 33.218% of the shares of Organogenesis Holdings Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-01-09Albert EraniSELL1979214.37
2023-04-12Albert EraniSELL250002.07

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Organogenesis Holdings Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0370.025+48%0.050-26%0.088-58%0.068-46%
Book Value Per Share--2.1122.056+3%1.925+10%1.239+70%1.468+44%
Current Ratio--2.7952.840-2%2.753+2%2.381+17%2.204+27%
Debt To Asset Ratio--0.3940.401-2%0.433-9%0.576-32%0.440-10%
Debt To Equity Ratio--0.6510.668-3%0.766-15%2.441-73%1.668-61%
Dividend Per Share---0.000-100%-0%0.000-100%0.000-100%
Eps---0.0040.026-117%0.029-115%0.038-111%0.008-155%
Free Cash Flow Per Share--0.0550.012+354%-0.017+131%-0.010+118%-0.022+140%
Free Cash Flow To Equity Per Share--0.0420.002+2232%-0.021+151%0.033+28%0.102-59%
Gross Profit Margin--1.0001.0000%0.839+19%0.968+3%0.979+2%
Intrinsic Value_10Y_max---3.691--------
Intrinsic Value_10Y_min---3.038--------
Intrinsic Value_1Y_max--0.006--------
Intrinsic Value_1Y_min--0.007--------
Intrinsic Value_3Y_max---0.267--------
Intrinsic Value_3Y_min---0.250--------
Intrinsic Value_5Y_max---0.887--------
Intrinsic Value_5Y_min---0.799--------
Market Cap301535455.000-79%539728670.000421714341.495+28%610620334.990-12%892683520.432-40%873097014.150-38%
Net Profit Margin---0.0060.031-118%0.035-116%0.022-126%-0.095+1563%
Operating Margin--0.0070.023-72%0.040-84%0.023-72%0.097-93%
Operating Ratio--0.9930.968+3%0.951+5%0.969+3%0.948+5%
Pb Ratio1.082-79%1.9371.541+26%2.428-20%12.549-85%9.088-79%
Pe Ratio-132.718+44%-237.557-57.922-76%859.585-128%161.504-247%181.361-231%
Price Per Share2.285-79%4.0903.180+29%4.608-11%6.720-39%6.587-38%
Price To Free Cash Flow Ratio10.342-79%18.51229.776-38%-15.158+182%3.838+382%-290.907+1671%
Price To Total Gains Ratio62.601-79%112.05134.516+225%179.517-38%53.393+110%621.830-82%
Quick Ratio--2.3142.373-2%2.386-3%1.938+19%2.286+1%
Return On Assets---0.0010.008-116%0.009-114%0.006-120%0.002-150%
Return On Equity---0.0020.013-116%0.016-113%-0.067+3200%-0.049+2325%
Total Gains Per Share--0.0370.025+48%0.050-26%0.088-59%0.068-47%
Usd Book Value--278663000.000272627750.000+2%254902500.000+9%164464750.000+69%194314620.484+43%
Usd Book Value Change Per Share--0.0370.025+48%0.050-26%0.088-58%0.068-46%
Usd Book Value Per Share--2.1122.056+3%1.925+10%1.239+70%1.468+44%
Usd Dividend Per Share---0.000-100%-0%0.000-100%0.000-100%
Usd Eps---0.0040.026-117%0.029-115%0.038-111%0.008-155%
Usd Free Cash Flow--7289000.0001638250.000+345%-2259750.000+131%-1291700.000+118%-2889632.129+140%
Usd Free Cash Flow Per Share--0.0550.012+354%-0.017+131%-0.010+118%-0.022+140%
Usd Free Cash Flow To Equity Per Share--0.0420.002+2232%-0.021+151%0.033+28%0.102-59%
Usd Market Cap301535455.000-79%539728670.000421714341.495+28%610620334.990-12%892683520.432-40%873097014.150-38%
Usd Price Per Share2.285-79%4.0903.180+29%4.608-11%6.720-39%6.587-38%
Usd Profit---568000.0003471500.000-116%4133000.000-114%5140750.000-111%3110667.194-118%
Usd Revenue--99651000.000108285000.000-8%112973250.000-12%97618550.000+2%69508228.701+43%
Usd Total Gains Per Share--0.0370.025+48%0.050-26%0.088-59%0.068-47%
 EOD+3 -5MRQTTM+20 -15YOY+15 -195Y+19 -1710Y+17 -19

4.2. Fundamental Score

Let's check the fundamental score of Organogenesis Holdings Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-132.718
Price to Book Ratio (EOD)Between0-11.082
Net Profit Margin (MRQ)Greater than0-0.006
Operating Margin (MRQ)Greater than00.007
Quick Ratio (MRQ)Greater than12.314
Current Ratio (MRQ)Greater than12.795
Debt to Asset Ratio (MRQ)Less than10.394
Debt to Equity Ratio (MRQ)Less than10.651
Return on Equity (MRQ)Greater than0.15-0.002
Return on Assets (MRQ)Greater than0.05-0.001
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Organogenesis Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.768
Ma 20Greater thanMa 502.838
Ma 50Greater thanMa 1002.985
Ma 100Greater thanMa 2003.318
OpenGreater thanClose2.950
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Long-term Assets Other  1,520-571,463-701,393-721,321-11,202-9,881



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets460,025
Total Liabilities181,362
Total Stockholder Equity278,663
 As reported
Total Liabilities 181,362
Total Stockholder Equity+ 278,663
Total Assets = 460,025

Assets

Total Assets460,025
Total Current Assets225,044
Long-term Assets234,981
Total Current Assets
Cash And Cash Equivalents 104,338
Net Receivables 81,999
Inventory 28,253
Other Current Assets 10,454
Total Current Assets  (as reported)225,044
Total Current Assets  (calculated)225,044
+/-0
Long-term Assets
Property Plant Equipment 156,346
Goodwill 28,772
Intangible Assets 15,871
Other Assets 0
Long-term Assets  (as reported)234,981
Long-term Assets  (calculated)200,989
+/- 33,992

Liabilities & Shareholders' Equity

Total Current Liabilities80,509
Long-term Liabilities100,853
Total Stockholder Equity278,663
Total Current Liabilities
Short-term Debt 19,711
Short Long Term Debt 5,486
Accounts payable 30,724
Other Current Liabilities 30,074
Total Current Liabilities  (as reported)80,509
Total Current Liabilities  (calculated)85,995
+/- 5,486
Long-term Liabilities
Long term Debt 60,745
Capital Lease Obligations Min Short Term Debt33,409
Long-term Liabilities Other 1,213
Long-term Liabilities  (as reported)100,853
Long-term Liabilities  (calculated)95,367
+/- 5,486
Total Stockholder Equity
Common Stock13
Retained Earnings -40,971
Other Stockholders Equity 319,621
Total Stockholder Equity (as reported)278,663
Total Stockholder Equity (calculated)278,663
+/-0
Other
Capital Stock13
Cash and Short Term Investments 104,338
Common Stock Shares Outstanding 131,858
Liabilities and Stockholders Equity 460,025
Net Debt 15,013
Net Invested Capital 344,894
Net Working Capital 144,535
Property Plant and Equipment Gross 229,532
Short Long Term Debt Total 119,351



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
> Total Assets 
0
594
301,743
311,436
311,239
311,565
312,058
312,792
313,790
314,981
316,309
163,678
176,453
168,074
174,640
220,687
208,340
216,487
246,428
294,494
319,181
355,564
370,423
443,259
436,272
456,357
457,272
449,359
446,107
450,313
462,647
460,025
460,025462,647450,313446,107449,359457,272456,357436,272443,259370,423355,564319,181294,494246,428216,487208,340220,687174,640168,074176,453163,678316,309314,981313,790312,792312,058311,565311,239311,436301,7435940
   > Total Current Assets 
0
106
1,743
1,436
880
603
360
294
269
160
25
71,131
85,062
76,146
80,843
125,600
111,398
117,706
129,010
174,344
185,239
201,763
211,835
226,979
217,851
231,543
230,526
222,609
216,822
216,435
225,573
225,044
225,044225,573216,435216,822222,609230,526231,543217,851226,979211,835201,763185,239174,344129,010117,706111,398125,60080,84376,14685,06271,131251602692943606038801,4361,7431060
       Cash And Cash Equivalents 
0
106
1,721
1,040
486
286
118
126
99
64
3
21,291
30,561
20,040
22,974
60,174
46,898
40,455
36,512
84,394
77,458
89,790
102,237
113,929
107,897
112,279
107,250
102,478
88,694
88,917
98,226
104,338
104,33898,22688,91788,694102,478107,250112,279107,897113,929102,23789,79077,45884,39436,51240,45546,89860,17422,97420,04030,56121,291364991261182864861,0401,7211060
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
958
853
0
0
1,157
0
0
001,157008539580000000000000000000000000
       Net Receivables 
0
0
0
0
360
587
40
8,490
319
23,089
28,956
34,077
32,509
34,157
34,383
39,359
32,724
44,024
56,915
56,804
72,003
76,767
74,583
82,460
79,477
88,824
93,115
89,450
92,021
93,615
89,276
81,999
81,99989,27693,61592,02189,45093,11588,82479,47782,46074,58376,76772,00356,80456,91544,02432,72439,35934,38334,15732,50934,07728,95623,0893198,490405873600000
       Other Current Assets 
0
0
0
396
-360
-587
-40
169
170
96
22
2,328
3,918
3,113
3,117
2,953
5,164
4,366
5,327
4,935
5,557
1,655
137
4,969
45
43
36
5,086
9,847
51
37
10,454
10,45437519,8475,0863643454,9691371,6555,5574,9355,3274,3665,1642,9533,1173,1133,9182,3282296170169-40-587-360396000
   > Long-term Assets 
0
487
300,000
310,000
310,360
310,962
311,698
312,498
313,521
314,821
316,284
92,547
91,391
91,928
93,797
95,087
96,942
98,781
117,418
120,150
133,942
153,801
158,588
216,280
218,421
224,814
226,746
226,750
229,285
233,878
237,074
234,981
234,981237,074233,878229,285226,750226,746224,814218,421216,280158,588153,801133,942120,150117,41898,78196,94295,08793,79791,92891,39192,547316,284314,821313,521312,498311,698310,962310,360310,000300,0004870
       Property Plant Equipment 
0
0
0
0
0
0
5,154
12,713
41,451
41,451
41,056
39,623
39,454
40,751
44,254
47,184
50,071
53,033
55,937
60,068
75,137
96,270
101,296
128,304
131,736
139,152
142,381
145,655
149,476
155,369
159,866
156,346
156,346159,866155,369149,476145,655142,381139,152131,736128,304101,29696,27075,13760,06855,93753,03350,07147,18444,25440,75139,45439,62341,05641,45141,45112,7135,154000000
       Goodwill 
0
0
0
0
0
0
3,126
7,710
25,539
25,539
25,539
25,539
25,539
25,539
25,539
25,539
25,539
25,539
28,916
28,772
28,772
28,772
28,772
28,772
28,772
28,772
28,772
28,772
28,772
28,772
28,772
28,772
28,77228,77228,77228,77228,77228,77228,77228,77228,77228,77228,77228,77228,77228,91625,53925,53925,53925,53925,53925,53925,53925,53925,53925,5397,7103,126000000
       Intangible Assets 
0
0
0
0
0
0
3,642
8,984
27,925
27,925
27,008
26,091
24,592
23,844
22,314
20,797
19,981
19,164
31,849
30,622
29,379
28,136
26,896
25,673
24,452
23,231
22,010
20,789
19,560
18,330
17,101
15,871
15,87117,10118,33019,56020,78922,01023,23124,45225,67326,89628,13629,37930,62231,84919,16419,98120,79722,31423,84424,59226,09127,00827,92527,9258,9843,642000000
       Other Assets 
0
0
0
0
0
0
192
475
1,580
1,580
1,558
1,294
1,310
1,794
1,690
1,567
1,351
1,045
716
688
654
623
1,624
33,531
33,461
33,659
33,583
31,534
0
31,407
0
0
0031,407031,53433,58333,65933,46133,5311,6246236546887161,0451,3511,5671,6901,7941,3101,2941,5581,5801,580475192000000
> Total Liabilities 
0
610
11,104
11,328
10,991
10,936
13,546
14,779
15,912
16,746
13,138
116,637
143,894
144,876
161,832
165,104
168,045
180,737
180,954
148,410
161,889
176,642
181,249
201,224
193,044
201,972
200,944
183,690
182,406
179,031
185,782
181,362
181,362185,782179,031182,406183,690200,944201,972193,044201,224181,249176,642161,889148,410180,954180,737168,045165,104161,832144,876143,894116,63713,13816,74615,91214,77913,54610,93610,99111,32811,1046100
   > Total Current Liabilities 
0
610
604
478
141
86
2,696
3,929
5,062
5,896
8,010
66,388
52,307
50,399
56,729
59,894
54,825
66,058
66,245
68,217
74,009
84,545
81,000
82,005
76,792
88,230
89,273
75,023
76,076
73,455
81,482
80,509
80,50981,48273,45576,07675,02389,27388,23076,79282,00581,00084,54574,00968,21766,24566,05854,82559,89456,72950,39952,30766,3888,0105,8965,0623,9292,696861414786046100
       Short-term Debt 
0
175
300
0
0
0
0
100
300
475
700
10,046
2,337
2,442
2,872
3,057
4,856
9,994
15,140
20,285
24,749
31,138
15,384
14,641
15,002
18,943
20,132
16,246
17,169
20,363
21,909
19,711
19,71121,90920,36317,16916,24620,13218,94315,00214,64115,38431,13824,74920,28515,1409,9944,8563,0572,8722,4422,33710,04670047530010000003001750
       Short Long Term Debt 
0
0
0
0
0
0
0
0
27,980
27,980
6,537
2,545
0
0
0
0
1,667
6,667
11,667
16,666
16,875
22,500
2,186
2,656
3,126
3,596
5,004
4,538
5,009
5,480
5,483
5,486
5,4865,4835,4805,0094,5385,0043,5963,1262,6562,18622,50016,87516,66611,6676,6671,66700002,5456,53727,98027,98000000000
       Accounts payable 
0
175
580
0
0
0
2,332
5,752
26,751
26,751
18,585
19,165
24,575
22,278
28,251
28,387
26,208
29,944
24,007
23,381
23,877
26,789
28,488
29,339
27,935
36,373
37,952
32,330
30,310
27,390
26,784
30,724
30,72426,78427,39030,31032,33037,95236,37327,93529,33928,48826,78923,87723,38124,00729,94426,20828,38728,25122,27824,57519,16518,58526,75126,7515,7522,3320005801750
       Other Current Liabilities 
0
260
853
478
141
86
2,696
3,829
4,762
5,421
7,310
6,762
4,923
5,472
5,506
5,810
5,340
5,626
4,974
2,059
2,158
1,876
1,918
2,303
33,855
32,914
31,189
26,447
28,597
766
745
30,074
30,07474576628,59726,44731,18932,91433,8552,3031,9181,8762,1582,0594,9745,6265,3405,8105,5065,4724,9236,7627,3105,4214,7623,8292,696861414788532600
   > Long-term Liabilities 
0
350
10,500
10,850
10,850
10,850
10,850
10,850
10,850
10,850
5,128
50,249
91,587
94,477
105,103
105,210
113,220
114,679
114,709
80,193
87,880
92,097
100,249
119,219
116,252
113,742
111,671
108,667
106,330
105,576
104,300
100,853
100,853104,300105,576106,330108,667111,671113,742116,252119,219100,24992,09787,88080,193114,709114,679113,220105,210105,10394,47791,58750,2495,12810,85010,85010,85010,85010,85010,85010,85010,5003500
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
49,216
85,728
87,801
97,976
97,549
105,149
0
0
64,486
63,392
56,843
72,498
70,769
0
0
0
66,231
0
0
0
0
000066,23100070,76972,49856,84363,39264,48600105,14997,54997,97687,80185,72849,21600000000000
       Other Liabilities 
0
0
0
0
0
0
1,297
3,200
10,907
10,907
10,987
1,033
5,859
6,676
7,127
7,661
8,071
9,361
15,118
15,707
13,457
11,030
3,547
1,557
1,060
1,073
1,090
1,122
0
1,190
0
0
001,19001,1221,0901,0731,0601,5573,54711,03013,45715,70715,1189,3618,0717,6617,1276,6765,8591,03310,98710,90710,9073,2001,297000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
428
428
385
318
0
184
92
92
0
370
370
370
370
370
1,223
1,223
1,223
0
0
0
0
1,223
0
0
001,22300001,2231,2231,22337037037037037009292184031838542842800000000
> Total Stockholder Equity
0
-16
290,639
300,108
300,248
300,629
298,512
298,014
297,878
298,235
303,171
47,041
32,559
23,198
12,808
55,583
40,295
35,750
65,474
146,084
157,292
178,922
189,174
242,035
243,228
254,385
256,328
265,669
263,701
271,282
276,865
278,663
278,663276,865271,282263,701265,669256,328254,385243,228242,035189,174178,922157,292146,08465,47435,75040,29555,58312,80823,19832,55947,041303,171298,235297,878298,014298,512300,629300,248300,108290,639-160
   Common Stock
0
1
285,640
295,108
295,249
295,630
293,513
293,015
292,879
293,236
298,172
9
9
9
9
10
11
11
11
13
13
13
13
13
13
13
13
13
13
13
13
13
13131313131313131313131313111111109999298,172293,236292,879293,015293,513295,630295,249295,108285,64010
   Retained Earnings Total Equity000-48,885-45,301-52,787-53,002-60,046-60,133-111,828-120,129-140,816-153,0580000000000000000000
   Accumulated Other Comprehensive Income 0000000000000-68,559-67,604-66,713-65,812-64,977-64,185-63,337-62,43500000000-65-410
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
177,272
178,124
178,412
179,408
226,580
227,604
0
0
299,129
298,095
299,038
300,989
302,155
303,261
307,374
309,102
310,957
312,573
0
0
0
000312,573310,957309,102307,374303,261302,155300,989299,038298,095299,12900227,604226,580179,408178,412178,124177,27200000000000
   Treasury Stock00000000000000000000000000000000
   Other Stockholders Equity 
0
65
90
5,233
5,092
4,712
6,829
7,327
7,462
7,105
2,169
177,272
178,124
178,412
179,408
226,580
227,604
228,225
237,015
299,129
298,095
299,038
300,989
302,155
303,261
307,374
309,102
310,957
312,573
314,838
317,254
319,621
319,621317,254314,838312,573310,957309,102307,374303,261302,155300,989299,038298,095299,129237,015228,225227,604226,580179,408178,412178,124177,2722,1697,1057,4627,3276,8294,7125,0925,23390650



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue433,140
Cost of Revenue-123,350
Gross Profit309,790309,790
 
Operating Income (+$)
Gross Profit309,790
Operating Expense-293,469
Operating Income16,32116,321
 
Operating Expense (+$)
Research Development44,380
Selling General Administrative276,666
Selling And Marketing Expenses0
Operating Expense293,469321,046
 
Net Interest Income (+$)
Interest Income0
Interest Expense-2,190
Other Finance Cost-532
Net Interest Income-1,658
 
Pretax Income (+$)
Operating Income16,321
Net Interest Income-1,658
Other Non-Operating Income Expenses0
Income Before Tax (EBT)10,39222,250
EBIT - interestExpense = 14,131
10,392
7,135
Interest Expense2,190
Earnings Before Interest and Taxes (EBIT)16,32112,582
Earnings Before Interest and Taxes (EBITDA)39,770
 
After tax Income (+$)
Income Before Tax10,392
Tax Provision-7,943
Net Income From Continuing Ops12,9992,449
Net Income4,945
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses416,819
Total Other Income/Expenses Net-5,9291,658
 

Technical Analysis of Organogenesis
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Organogenesis. The general trend of Organogenesis is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Organogenesis's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Organogenesis Holdings Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 2.51 < 2.51 < 2.52.

The bearish price targets are: 2.475 > 1.96 > 1.855.

Tweet this
Organogenesis Holdings Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Organogenesis Holdings Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Organogenesis Holdings Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Organogenesis Holdings Inc. The current macd is -0.05192937.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Organogenesis price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Organogenesis. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Organogenesis price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Organogenesis Holdings Inc Daily Moving Average Convergence/Divergence (MACD) ChartOrganogenesis Holdings Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Organogenesis Holdings Inc. The current adx is 16.42.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Organogenesis shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Organogenesis Holdings Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Organogenesis Holdings Inc. The current sar is 3.065.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Organogenesis Holdings Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Organogenesis Holdings Inc. The current rsi is 30.77. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Organogenesis Holdings Inc Daily Relative Strength Index (RSI) ChartOrganogenesis Holdings Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Organogenesis Holdings Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Organogenesis price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Organogenesis Holdings Inc Daily Stochastic Oscillator ChartOrganogenesis Holdings Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Organogenesis Holdings Inc. The current cci is -280.28234922.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Organogenesis Holdings Inc Daily Commodity Channel Index (CCI) ChartOrganogenesis Holdings Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Organogenesis Holdings Inc. The current cmo is -51.00543447.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Organogenesis Holdings Inc Daily Chande Momentum Oscillator (CMO) ChartOrganogenesis Holdings Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Organogenesis Holdings Inc. The current willr is -86.66666667.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Organogenesis Holdings Inc Daily Williams %R ChartOrganogenesis Holdings Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Organogenesis Holdings Inc.

Organogenesis Holdings Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Organogenesis Holdings Inc. The current atr is 0.21070913.

Organogenesis Holdings Inc Daily Average True Range (ATR) ChartOrganogenesis Holdings Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Organogenesis Holdings Inc. The current obv is -23,915,332.

Organogenesis Holdings Inc Daily On-Balance Volume (OBV) ChartOrganogenesis Holdings Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Organogenesis Holdings Inc. The current mfi is 50.01.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Organogenesis Holdings Inc Daily Money Flow Index (MFI) ChartOrganogenesis Holdings Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Organogenesis Holdings Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Organogenesis Holdings Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Organogenesis Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.768
Ma 20Greater thanMa 502.838
Ma 50Greater thanMa 1002.985
Ma 100Greater thanMa 2003.318
OpenGreater thanClose2.950
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Organogenesis with someone you think should read this too:
  • Are you bullish or bearish on Organogenesis? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Organogenesis? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Organogenesis Holdings Inc

I send you an email if I find something interesting about Organogenesis Holdings Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Organogenesis Holdings Inc.

Receive notifications about Organogenesis Holdings Inc in your mailbox!